IP service providers: a more cost-effective solution post M&A?
With specialist IP providers offering post-M&A services at lower cost than traditional law firms, have clients been overspending in the past? Melissa Pillote on behalf of Dennemeyer reports.
- Technology transfer: A smart way of working 14-10-2016
- Working together wisely 12-10-2016
- What drives the urge to merge? 10-10-2016
- A state of flux: life sciences law in Australia 16-08-2016
- Running an efficient clinical drug trial 19-07-2016
Latest asia-pacific news
Sanofi leads the way for gene therapy patents: report
18-10-2017
CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall.
China launches life sciences IP centre
02-08-2017
